Celgene Corporation Reports Strong Third Quarter 2013 Operating and Financial Results

Published: Oct 24, 2013

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Celgene Corporation (NASDAQ:CELG) reported third quarter 2013 total revenue of $1,674 million compared to $1,419 million in the third quarter 2012. Net product sales were $1,644 million, an 18 percent increase from the same period in 2012. Adjusted net income for the third quarter of 2013 increased 19 percent to $669 million compared to $561 million in the third quarter of 2012. For the same period, adjusted diluted earnings per share (EPS) increased 21 percent to $1.56 from $1.29.

Help employers find you! Check out all the jobs and post your resume.

Back to news